Two-Stage Liver Carcinogenesis in the Mouse*
|
|
- Nora Clarke
- 6 years ago
- Views:
Transcription
1 SYMPOSIUM Agents and Processes in Chemical Carcinogenesis TOXICOLOGIC PATHOLOGY ISSN: Volume 15, Number 2, 1987 Copyright by the Society of Toxicologic Pathologists Two-Stage Liver Carcinogenesis in the Mouse* GIUSEPPE DELLA PORTA, TOMMASO A. DRAGANI, AND GIACOMO MANENTI Dirisioiie di OncoIogia Sperirnentale A, Istittito Nazionaleper lo Studio e la Cirra dei Tirnrori, Via G. Venezian Milano, Italy ABSTRACT A two-stage protocol for studying liver carcinogenesis was applied to the mouse. The protocol includes the treatment of 7-day-old mice with a single low dose of an initiating agent (diethylnitrosamine, NDEA), promotion starting after weaning and lasting about 20 weeks, and histologic analysis, at 30 weeks of age, of hepatocellular nodules on H&E stained sections. A stereologic analysis of results allows the evaluation of nodule frequency and size. Using this protocol in and mice, we have identified the promoting activity of the phenobarbital-like enzyme inducer, 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), which was found to be a strong hyperplaseogenic agent for mouse liver. These studies also indicated that the different susceptibility to hepatocarcinogenesis in and mice may be related to a higher susceptibility of than initiated liver cells to growth stimulation. A long-term study showed that mice have a low incidence of spontaneous liver tumors but are susceptible to chemical hepatocarcinogenesis and, therefore, they may be an alternative model to mice in carcinogenesis bioassays. INTRODUCTION The two-stage nature of tumor development was demonstrated in the skin of rodents by applying a single subthreshold dose of an initiating carcinogen (DMBA) followed by the continuous treatment with the promoter croton oil (2, 3). The single subthreshold dose of the initiating carcinogen or the continuous treatment with the promoter alone were not able to induce tumors, but the combined treatment did (2,3). In the last two decades it has become clear that the two-stage phenomenon in the development of neoplasms is not unique to the skin. Multi-stage induction of tumors was observed in other organs and tissues such as liver, lungs, mammary gland, and urinary bladder, and different tumor promoters have been identified (1, 10, 11, 12, 19, 22). The liver model of carcinogenesis seems to be particularly useful for studying the different phases of tumor development. Since up to 80% of liver mass is constituted by a single cell type, the hepatocyte and the organ is quite well characterized biochemically in its many functions. Moreover, the early phases of multi-stage hepatocarcinogenesis are characterized by preneoplastic lesions, which can be induced in a few months. Different systems are available to induce preneoplastic lesions in a short time or tumors after a longer period * Presented at the Third Sardinian International Symposium, October 6-9, 1985 in Cagliari, Italy. of observation. The systems consist of a single treatment with an initiating carcinogen, usually NDEA, during or before liver cell replication. Then a promoting agent such as phenobarbital (PB), or a choline deficient diet, or a toxic environment (AAFdiet) that inhibits proliferation of normal hepatocytes is administered, which enables identification ofenzyme-altered foci that are considered to be preneoplastic lesions (9, 12). GENETIC SUSCEPTIBILITY TO HEPATOCARCINOGENESIS These systems have been studied mostly in the rat, whereas the mouse has been used in a few studies only. This species seems particularly useful to investigate the genetic mechanisms controlling tumor development because murine strains are available with a high or low incidence of spontaneous liver tumors. As shown in Table I, murine strains like C57BLl 65 and SWR do not develop liver tumors, even after 2 years of life. BALB/c mice have a low incidence of liver tumors, whereas C3Hf mice have a high incidence (4, 5). To better define the mouse model of hepatocarcinogenesis, we carried out a long-term experiment to compare the spontaneous tumor incidence in two related hybrids: and mice, both derived from the F1 cross between C57BL/6J females and either C3Hf or BALB/c males. mice are com- 229
2 ~ ~ ~~ 230 DELLA PORTA ET AL TOXICOLOGIC PATHOLOGY TABLE 1.-Incidence of spontaneous liver tumors in different murine strains after observation until 120 weeks of age. Mice with liver tumors Strain or hybrid Sex mice No. (Yo) CS 7BL/6Ja M 50 F 50 C3HP M SWR" M 45 F 47 F BALB/cb M F From reference (4). From reference (5). monly used in carcinogenesis bioassays carried out under the National Toxicology Program sponsorship in the United States. As shown in Table 11, and as reported by other authors (20), the hybrid inherited from the C3Hfparental generation a relatively high incidence of spontaneous liver tumors. Therefore, the high incidence of spontandous liver tumors acts as a dominating trait. In contrast, mice showed a low incidence of spontaneous liver tumors (8). To determine the susceptibility of the two hybrids to a weak multipotential carcinogen, urethan, we carried out the experiment shown in Table 11. Urethan is an effective liver carcinogen when administered during infancy even for short periods oftime. Urethan treatment induced a high percentage of liver tumors in both hybrids. However, mice survived longer than mice. For this reason the incidence of liver tumors seems higher in mice, but a statistical analysis, which takes the survival into consideration, showed that mice were more susceptible than mice. Our study showed that mice have a low incidence of spontaneous liver tumors, but they are susceptible to chemical hepatocarcinogenesis and, therefore, they may be an alternative to in carcinogenesis bioassays (8). TWO-STAGE HEPATOCARCINOGENESIS In studying mouse hepatocarcinogenesis, it must be taken into account that this model differs in some aspects from the skin model. A single low dose of an initiating agent does not result in tumor development in the skin even after a prolonged period of observation; whereas a single dose of diethylnitrosamine at 1.25 mg/kg induced hepatocellular carcinomas in 15-day-old mice within 7O'weeks after treatment (18). Therefore, a progression of neo- TABLE 11.-Hepatocellular tumors in untreated or urethan-treated and mice." Hybrid Sex mice Treatment M 50 - M 48 - F 50 - F 49 - M 41 urethan M 46 urethan F 51 urethan F 50 urethan Mice with liver tumors No. Ratiob ' = From reference (8). Observedlexpected ratio for tumor incidence comparing the two hybrids, allowing for survival. =p < 0.01, two-tailed, between the two hybrids. plastic lesions must be operating in the mouse liver, which may be due to the presence of endogenous promoters of hepatocarcinogenesis. Some hormones have been found to promote liver carcinogenesis, and they may account for the well known sex difference in the susceptibility to hepatocarcinogenesis. Our studies were started on two-stage hepatocarcinogenesis choosing a protocol in which a single low dose of initiating agent is administered to 7- day-old mice. After an observation period of 3-6 months, the animals are sacrificed and the number and size of hepatocellular nodules are measured in hematoxylin and eosin (H&E) stained liver sections. The initiation treatment given during infancy (period of physiologic liver cell replication) reduces at minimum the manipulation of the system, and avoids stressing the animals with partial hepatectomy or treatment with necrogenic doses of toxins, as it is commonly done with the adult rat. The analysis of hepatocellular nodules on H&E slides was chosen because it was considered more reliable and had a clearer biologic significance than the analysis of enzyme altered foci, Noteworthy, the best enzymatic marker for preneoplastic foci in the rat liver (gamma-glutamyltranspeptidase) (9, 12) is a poor marker for mouse hepatocellular nodules (1 7). A stereological method for the analysis of data allows the calculation of nodule frequency (number of nodules/cm3 of liver) and size (mean volume of nodules) (I 5). In our study, as well as in others, most hepato: cellular nodules induced by treatment withsthe initiating agent alone (NDEA) were basophilic and may be scored starting from 14 weeks of age. In male mice, nodule frequency and size progressively increased from 14 to 24 weeks of age (Table 111).
3 Vol. 15, No. 2, 1987 LIVER CARCINOGENESIS 23 1 TABLE 111.-Hepatocellular nodules in male mice treated once with NDEA (15 mdkg PO) at 1 week of age, and observed until 9-24 weeks of age. Mean volume" Age mice ~o./cm3a (mm3 x lo3) f f & f 8 a Values represent mean? SE. Therefore, an observation period of about 20 weeks of age is advisable when using this model. In a first series of experiments we used PB and 1,4-bis[2-(3,5-dichloropyridiloxy)]benzene (TCPO- BOP) as promoters. PB is a well known promoter of rat hepatocarcinogenesis and in some experiments it was shown to promote mouse hepatocarcinogenesis as well (1 2, 16,2 1). PB stimulates a number ofenzyme activities involved in drug metabolism and also DNA synthesis in the liver, although the relevance of these effects on the promotion of hepatocarcinogenesis is still not clear (12). A potent PB-like agonist, with regard to induction of drug metabolism, has been recently described by Poland et a1 (13, 14). TCPOBOP is 650-fold more potent in mice than PB, but it is ineffective in rats. The compound has not been studied for promoting activity on hepatocarcinogenesis. In preliminary experiments, we confirmed the PBlike pattern of enzyme activity induced by TCPO- BOP in mouse liver, and we also observed a strong hyperplastic activity. As shown in Table IVY the P-450 associated enzyme activities p-nitroanisoleo-demethylase and aminopyrine-n-demethylase were induced by both PB and TCPOBOP; whereas, the P-448 associated UDPG-transferase activity (pnitrophenol as substrate) was not induced. The liver DNA content was almost doubled by TCPOBOP treatment (Table IV) (7). The results of the two-stage hepatocarcinogenesis experiment reported in Table V show that NDEA treatment of 7-day-old mice, followed by vehicle, resulted in about 400 nodules/cm3 of liver at 28 weeks of age in female mice. PB treatment after NDEA caused centrilobular hypertrophy with cells showing enlarged and acidophilic cytoplasm, resulted in a slight decrease of the number of nodules/cm3, and did not significantly change their mean volume with respect to controls. PB did not promote liver nodules probably due to the short period of administration or to an insufficient dose. Mice treated with TCPOBOP after NDEA had fewer nodules/ cm3 than controls, but the mean volume of nodules was higher. Most of the hepatocytes, throughout the lobules, were enlarged and acidophilic. Also, most of the nodules consisted of large acidophilic hepatocytes or ofclear cells. Therefore, TCPOBOP treatment stimulated the growth of hepatocellular nodules that were larger than those in controls. The reduced number of nodules/cm3 of liver in the TCPOBOP-treated group was due to nodule dilution caused by liver enlargement and to a confluence of small nodules in large ones (7). We have therefore identified TCPOBOP as a new promoter of mouse hepatocarcinogenesis. It may represent a valuable tool for the study of the mechanisms involved in the promotion phase of hepatocarcinogenesis and for the identification of a possible receptor that mediates its biologic activity. As already mentioned, the spontaneous incidence of hepatocellular tumors is high in mice and low in mice. To investigate whether the different susceptibility to hepatocarcinogenesis is due to a different susceptibility to initiation or promotion phases of hepatocarcinogenesis, both hybrids were treated with a single dose of NDEA at 1 week of age followed by TCPOBOP or vehicle and sacrificed at 30 weeks of age. The frequency of hepatocellular nodules was similar in the two hybrids. However, the mean volume of nodules was about 10-fold greater in than male mice receiving NDEA plus vehicle. The treatment with TCPOBOP after NDEA increased the mean volume ofnodules 5-8-fold in both hybrids, with mice still having a value about 7-fold greater than TABLE 1V.-Effects of 4-week treatment with PB and TCPOBOP on microsomal enzyme activities in female mice..? p-nitroanisole- Aminopyrine- UDPG- Liver DNA Treatment OrdemethylaSeb N-demethylaseb transferaseb (me) Vehicle & f 0.5 PB 10.8 f 0.7' 43.6 & 1.8' 8.9 & f 0.6 TCPOBOP 14.5 & 0.4' 66.6 & 3.3' 8.1 k i- 1.1' From reference (7). Values are mean,k SE, 6 animals per group. Units represent nmol productlmidmg protein. cp < 0.01 when compared with vehicle-treated group.
4 232 DELLA PORTA ET AL TOXICOLOGIC PATHOLOGY mice. No differences in mean volume of nodules were seen in the females ofboth hybrids after NDEA and vehicle, whereas upon administration ofndea and TCPOBOP, the mean volume of nodules was 25-fold greater in than 'in females. TCPOBOP alone induced the same level of DNA synthesis and of aminopyrine-n-demethylase in the liver of both hybrids. Therefore, the different susceptibility to hepatocarcinogenesis in and mice may be related to a higher susceptibility of than -initiated liver cells to growth stimulation. ALTERATIONS IN GEN EXPRESSION IN MOUSE LIVER TUMORS The expression of endogenous retroviral sequences and ofthree cellular oncogenes were studied in three hepatocellular adenomas and in four carcinomas induced in male mice by a single dose of NDEA, in five spontaneous carcinomas in male C3Hf mice, and in the livers of normal agematched control mice. In all of these adenomas and carcinomas there was increased expression of Moloney murine leukemia virus (M-MuLV)- and intracisternal A particle (1AP)-related sequences. The retrovirus-like VL30 sequence was expressed at significant levels in the normal liver of these mice and increased expression of this sequence was found in only four of the 12 tumors examined. Expression of endogenous mouse mammary tumor virus (MMTV)-related sequences was not detected in the normal livers nor in any of the liver tumors. With respect to cellular oncogenes, increased expression of c-niyc was seen in all of the tumors. Two out of five normal liver samples and all of the tumors of the C3Hf mice displayed significant expression of c-iizyc. There was a slight increase in expression of c-ha-ras in some ofthe tumors. Increased expression of c-fos was found in only one of the 12 tumors. Taken together, these studies indicate that both carcinogen-induced and spontaneous liver tumor formation in mice is associated with abnormalities in the expression of endogenous retrovirus-related DNA sequences and also specific cellular oncogenes (6). In conclusion, the mouse liver system may represent a good model to study the different phases of carcinogenesis. The sensitivity of infant liver to carcinogens may enable us to study the hepatocarcinogenicity of chemicals in a medium-term (20-30 weeks) in viw carcinogenesis assay. The studies on the genetic differences in the susceptibility to hepatocarcinogenesis between murine strains may lead to insights into the underlying mechanisms responsible for these differences. The understanding of these mechanisms may be of generic value, not limited TABLE V.-Hepatocellular nodules in female mice after various treatments." Hepatocellular nodules Treatment after Volume NDEA mice No./cm3 (mm3 x 10') Vehicle f: 51 9k2 PB gb 12 k 3 TCPOBOP f 19"d '~' From reference (7). Mice were treated once with NDEA (15 mg/kg PO) at 7 days of age and then with PB (500 ppm in the drinking water continuously) and TCPOBOP (3 mg/kg ip every week) starting from 8 weeks ofage, for 20 weeks; values represent mean k SE. *The single hepatocellular carcinoma observed (14 mm diameter) was excluded from tabulation. Including 11 nodules of mm in diameter. dp < 0.01 with respect to the vehicle-treated group. to the particular mouse system, and may allow the identification of factors affecting tumor development. REFERENCES 1. Armuth V and Berenblum I (1974). Promotion of mammary carcinogenesis and leukemogenic action by phorbol in virgin female Wistar rats. Cancer Res. 34: Berenblum I and Shubik P (1947). A new quantitative approach to the study of stages of chemical carcinogenesis in the mouse's skin. 3r. J. Cattcer I: Boutwell RK (1964). Some biological aspects of skin carcinogenesis. Progr. Exp. Tirrrror Res. 4: Della Porta G, Capitano J, Parmi L, and Colnaghi MI (1967). Cancerogenesi da uretano in topi neonati, lattanti e adulti dei ceppi C57BL, C3H, BC3F1, C3Hf e SWR. Ttritiori 53: , 5. Dragani TA (1979). Analysis of tumor incidence in BALB/c mice used as controls in carcinogenicity experiments. Tirrrrori 65: Dragani TA, Manenti G, Della Porta G, Gattoni-Celli S, and Weinstein IB (1986). Expression of retroviral sequences and oncogenes in munne hepatocellular tumors. Cancer Res. 46: Dragani TA, Manenti G, Galliani G, and Della Porta G (1985). Promoting effects of 174-bis[2-(3,5-dichloropyridy1oxy)lbenzene in mouse hepatocarcinogenesis. Carcitiogenesis 6: Dragani TA, Sozzi G, and Della Porta G (1984). Spontaneous and urethan-induced tumor incidence in F1 versus Fl mice. Tiinrori 70: Farber E (1980). The sequential analysis of liver cancer induction. Biochim. Bioplrys. Acta 605: Hicks RM, Wakefield JSt J, and Chowaniec J (1973). Cocarcinogenic action of saccharin in the chemical induction of bladder cancer. Nature 243: Nadina D (1976). Preneoplastic lesions in munne mammary cancer. Catrcer Res. 36: Pitot HC and Sirica AE (1980). The stages of initia-
5 Vol. 15, No. 2, 1987 LIVER CARCINOGENESIS 233 tion and promotion in hepatocarcinogenesis. Biocliim. Biophys. Acta 605: Poland A, Mak I, and Glover E (1981). Species differences in responsiveness to 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharntacol. 20: Poland A, Mak I, Glover E, Boatman RJ, Ebetino F, and Kende AS (1980). 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharinacol. 18: Pugh TD, King JH, Koen H, Nychka D, Chover J, Wahba G, He Y, and Goldfarb S (1983). Reliable stereological method for estimating the number of microscopic hepatocellular foci from their transections. Cawer Res. 43: Uchida E and Hirono I(1979). Effect ofphenobarbital on induction of liver and lung tumors by dimethylnitrosamine in newborn mice. Ganit 70: Vesselinovitch SD, Hacker HJ, and Bannasch P (1985). Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Cancer Res. 45: Vesselinovitch SD and Mihailovich N (1983). Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res. 43: Wang CY, Hayashida S, Pamucku AM, and Bryan GT (1976). Enhancing effect of allopurinol on the induction of bladder cancer in rats by N-[4-(5-nitro- 2-furyl)-2-thiazolyl]formamide. Cancer Res. 36: Ward JM, Goodman DG, Squire RA, Chu KC, and Linhart MS (1979). Neoplastic and non neoplastic lesions in aging (C57BL/6N x C3H/HeN)Fl (F1) mice. J. Natl. Cancer Itzsf. 63: Ward JM, Rice JM, Creasia D, Lynch P, and Rigs C (1983). Dissimilar patterns of promotion by di(2- ethylhexy1)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in F1 mice. Carcirtogettesis 4: Witschi H, Williamson D, and Lock S (1977). Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J. Natl. Cancer Inst. 58:
Hepatocarcinogenesis: chemical models
Hepatocarcinogenesis: chemical models Introduction Earliest observations that human exposure to certain chemicals is related to an increased incidence of cancer John Hill 1761 Nasal cancer in snuff users
More informationComparative Prevalence, Multiplicity, and Progression of Spontaneous and Vinyl Carbamate-Induced Liver Lesions in Five Strains of Male Mice
TOXICOLOGIC PATHOLOGY, vol 30, no 5, pp 599 605, 2002 Copyright C 2002 by the Society of Toxicologic Pathology DOI: 10.1080/0192623029010577 6 Comparative Prevalence, Multiplicity, and Progression of Spontaneous
More informationOpinion on. Classification of Musk ketone
EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C7 - Risk assessment SCIENTIFIC COMMITTEE ON HEALTH AND ENVIRONMENTAL RISKS SCHER
More information3. Studies of Cancer in Experimental Animals
364 IARC MONOGRAPHS VOLUME 94 3. Studies of Cancer in Experimental Animals 3.1 Pure microcystin-lr (see Table 3.1) 3.1.1 Mouse A group of 13 male ICR mice, 5 weeks of age, received 100 intraperitoneal
More informationMammary Nodular Hyperplasia in Intact R hesus Monkeys
Vet. Path. 10: 130-134 (1973) Mammary Nodular Hyperplasia in Intact R hesus Monkeys L. W NELSON and L. D. SHOTT Department of Pathology and Toxicology, Mead Johnson Research Center, Evansville, Ind., and
More informationDevelopment of Selected Neoplasms of the Liver, Pancreas, and Urinary Bladder in Rodents
Environmental Health Perspectives Vol. 77, pp. 83-92, 1988 Comparative Histopathology of the Development of Selected Neoplasms of the Liver, Pancreas, and Urinary Bladder in Rodents by Dante G. Scarpelli*
More informationCorrelation between Bcl-2 Expression and
American Journal of Pathology, Vol. 151, No. 4, October 1997 Copyright American Societyfor Investigative Pathology Correlation between Bcl-2 Expression and Histopathology in Diethylnitrosamine-Induced
More informationDose Response Approaches for Nuclear Receptor Mediated Modes of Action Workshop Preliminary Report
Dose Response Approaches for Nuclear Receptor Mediated Modes of Action Workshop Preliminary Report Workshop Organizing Committee 2 Major Goals of the Workshop Determine whether the biology of nuclear receptors
More informationAbsence of Uniform Progressive Growth of Long-Term Transplants of Rat Liver Neoplastic Nodules 1,2,3
Absence of Uniform Progressive Growth of Long-Term Transplants of Rat Liver Neoplastic Nodules 1,2,3 Takaaki Ohmori, 4,5 Kenshi Watanabe, 4,6 and Gary M. Williams 4,7, e, 9 ABSTRACT-Fragments of normal
More information5. Summary of Data Reported and Evaluation
288 5. Summary of Data Reported and Evaluation 5.1 Exposure Oral contraceptives have been used since the early 1960s and are now used by about 90 million women worldwide. The pill is given as a combination
More informationJulia H. Carter, 1 Harry W. Carter, 1 James A. Deddens, 2 Bernadette M. Hurst, 1 Michael H. George, 3 and Anthony B. DeAngelo 3
Articles A 2-Year Dose Response Study of Lesion Sequences during Hepatocellular Carcinogenesis in the Male B6C3F 1 Mouse Given the Drinking Water Chemical Dichloroacetic Acid Julia H. Carter, 1 Harry W.
More informationA Wistar Rat Strain Prone to Spontaneous Liver Tumor Development: Implications for Carcinogenic Risk Assessment
Regulatory Toxicology and Pharmacology 36, 86 95 (2002) doi:10.1006/rtph.2002.1567 A Wistar Rat Strain Prone to Spontaneous Liver Tumor Development: Implications for Carcinogenic Risk Assessment Bennard
More informationProliferative Lesions of the Exocrine Pancreas in Male F344/N Rats
Environmental Health Perspectives Vol. 56, pp. 213-217, 1984 Proliferative Lesions of the Exocrine Pancreas in Male F344/N Rats By Gary A. Boorman* and Scot L. Eustis* While the rat pancreas is susceptible
More informationIMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS PDE FOR CUMENE
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE DRAFT CONSENSUS GUIDELINE IMPURITIES: GUIDELINE FOR RESIDUAL SOLVENTS Released for
More informationInfluence of the Age of Mice at Exposure to Radiation on. Life-shortening and Carcinogenesis
Influence of the Age of Mice at Exposure to Radiation on Life-shortening and Carcinogenesis SHUNSAKU SASAKI Division of Physiology and Pathology, National Institute of Radiological Sciences, 9-1, 4-Chome,
More informationThe Importance of ADME/PK to Inform Human Safety Assessments Based on Animal Studies: Example with Furan. Gregory L. Kedderis, PhD Chapel Hill, NC
The Importance of ADME/PK to Inform Human Safety Assessments Based on Animal Studies: Example with Furan Gregory L. Kedderis, PhD Chapel Hill, NC Conflict of Interest None This research was conducted at
More informationCOMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT
COMMITTEE ON CARCINOGENICITY OF CHEMICALS IN FOOD, CONSUMER PRODUCTS AND THE ENVIRONMENT STATEMENT ON A CARCINOGENICITY STUDY OF ASPARTAME BY THE EUROPEAN RAMAZZINI FOUNDATION COC/06/S2 December 2006 Introduction
More informationof 3-Aminophenol in B6D2F1 Mice
Summary of Drinking Water Carcinogenicity Study of 3-Aminophenol in B6D2F1 Mice July 2012 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted
More informationEFFECT OF VARIOUS FACTORS ON INDUCTION OF URINARY BLADDER TUMORS IN ANIMALS BY N-BUTYL-N-(4-HYDROXYBUTYL) NITROSOAMINE
[GANN, 64, 151-159; April, 1973] UDC 615.277.4: 616-006-021.6[616.62] EFFECT OF VARIOUS FACTORS ON INDUCTION OF URINARY BLADDER TUMORS IN ANIMALS BY N-BUTYL-N-(4-HYDROXYBUTYL) NITROSOAMINE (Plate XXI)
More informationORIGIN OF LEUKEMIC CELLS IN MOUSE LEUKEMIA INDUCED BY N-BUTYLNITROSOUREA*1. ed by cytotoxicity tests. Cells from leukemia without thymus involvement
[Gann, 66, 37-42; February, 1975] ORIGIN OF LEUKEMIC CELLS IN MOUSE LEUKEMIA INDUCED BY N-BUTYLNITROSOUREA*1 Hayase SHISA, Yasue MATSUDAIRA, Hiroshi HIAI, and Yasuaki NISHIZUKA Laboratory of Experimental
More informationInternational Agency for Research on Cancer (IARC) - Summaries & Evaluations
International Agency for Research on Cancer (IARC) - Summaries & Evaluations AFLATOXINS Naturally Occurring Aflatoxins (Group1) Aflatoxin M1 (Group 2B) For definition of Groups, see Preamble Evaluation.
More information5.15 HEXYTHIAZOX (176)
Hexythiazox 225 5.15 HEXYTHIAZOX (176) TOXICOLOGY Hexythiazox is the ISO approved name for (trans-5-(4-chlorophenyl)-n-cyclohexyl-4-methyl-2-oxo- 3-thiazolidine-carboxamide (CAS No. 78587-05-0). Hexythiazox
More informationEpoxide Hydrolase: A Marker for Experimental Hepatocarcinogenesis
ANNALS OF CLINICAL AND LABORATORY SCIENCE, Vol. 14, No. 1 Copyright 1984, Institute for Clinical Science, Inc. Epoxide Hydrolase: A Marker for Experimental Hepatocarcinogenesis MARTIN J. GRIFFIN, P h.d.,
More informationTR-469 Toxicology and Carcinogenesis Studies of AZT (CAS No ) and AZT/-Interferon A/D B6C3F1 Mice (Gavage Studies)
(This document has been reformatted unchanged from the original document except for the bold emphasis editing by Stuart Thomson, Director, the Gaia Research Institute. S.T.) TR-469 Toxicology and Carcinogenesis
More informationSupplementary Table. Overview of IPCS requirements for analyzing cancer mode of action. Metofluthrin 1 Momfluorothrin 2
Electronic Supplementary Material (ESI) for Toxicology Research. This journal is The Royal Society of Chemistry 2018 T. Yamada Page 1 of 6. Overview of IPCS requirements for analyzing cancer mode of action
More informationSUPPLEMENTARY INFORMATION GENOTOXICITY. In vitro Genotoxicity Studies
SUPPLEMENTARY INFORMATION GENOTOXICITY In vitro Genotoxicity Studies The in vitro immortalisation (IVIM) assay relies on the induction of a survival advantage by insertional activation of cellular proto-oncogenes,
More informationR. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam 3, V.E. Steele 4, S. De Flora 2
INCON / 10 ICMAA, Guarujà, Brazil, September 26-29, 2010 MECHANISMS OF INHIBITION OF CIGARETTE SMOKE GENOTOXICITY AND CARCINOGENICITY 1 2 3 4 R. Balansky 1,2, F. D Agostini 2, A. Izzotti 2, P. Kalpakam
More informationProliferative Lesions of the Glandular Stomach and Liver in F344 Rats Fed Diets Containing Aroclor 1254
Environmental Health Perspectives Vol. 60, pp. 89-95, 1985 Proliferative Lesions of the Glandular Stomach and Liver in F344 Rats Fed Diets Containing Aroclor 1254 by Jerrold M. Ward* Aroclor 1254 was fed
More informationExpert Statement on Metofluthrin (CLH Report, Version 2 of May 2015). Professor Brian G. Lake, Centre for Toxicology, University of Surrey,
Expert Statement on Metofluthrin (CLH Report, Version 2 of May 2015). Professor Brian G. Lake, Centre for Toxicology, University of Surrey, Guildford, Surrey, UK Comments on the mode of action (MOA) for
More informationGo AKAGI, AKIKO AKAGI, Masuo KIMURA, and Hisashi OTSUKA (2nd Department of Pathology, School of Medicine, Tokushima University*2) Synopsis
[GANN, 64, 331-336; August, 1973] UDC 616-006-021.6[616.62] COMPARISON OF BLADDER TUMORS INDUCED IN RATS AND MICE WITH N-BUTYL-N-(4-HYDROXYBUTYL)- NITROSOAMINE*1 (Plates LIII-LV) Go AKAGI, AKIKO AKAGI,
More informationInterface between adaptive and neoplastic growth in
Gut, 1987, 28, SI, 253-258 Interface between adaptive and neoplastic growth in the pancreas D S LONGNECKER From the Dartmouth Medical School, Hanover, NH, USA SUMMARY The adaptive changes of hypertrophy
More informationRole of aryl hydrocarbon receptor and inflammation in GI malignancies
1. SPECIFIC AIMS: Our preliminary data supports the idea that dioxins and related pollutants cause hepatocellular cancer in the mouse through an aryl hydrocarbon receptor (AHR) dependent mechanism that
More informationOverview of US EPA Assessment Activities for Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS)
Overview of US EPA Assessment Activities for Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) Jennifer Seed, PhD Risk Assessment Division Office of Pollution Prevention and Toxics US
More information(CBA) spontaneous hepatomas of benign character have occurred."2. Boyland and Brues2 have reported work on the carcinogenic
INDUCTION OF TUMORS BY 3:4:5:6-DIBENZCARBA- ZOLE IN MALE MICE OF THE CBA STRAIN, WHICH DEVELOPS SPONTANEOUS HEPATOMA* L. C. STRONG, G. M. SMITH, AND W. U. GARDNER Boyland and Brues2 have reported work
More informationXANTHINE OXIDASE ACTIVITY IN PROGRESSIVE SPONTANEOUS MAMMARY CARCINOG ENESIS
833 XANTHINE OXIDASE ACTIVITY IN PROGRESSIVE SPONTANEOUS MAMMARY CARCINOG ENESIS NANDINI A. SHETH, SUMATI V. BHIDE AND KAMAL J. RANADIVE Biology Division, Cancer Research Institute, Tata Memorial Centre,
More informationHealth Promotion by Antioxidants
Functional Foods in Health and Disease 2011,1(12):574-581 Page 574 of 581 Research Article Open Access Health Promotion by Antioxidants *Hoyoku Nishino 1,2, Michiaki Murakoshi 1,3, Yoshiko Satomi 4 1 KyotoPrefectural
More informationInterpretation of the liver hypertrophy in the toxicological evaluation of veterinary medicinal products
Provisional translation The Food Safety Commission Final decision on September 7, 2017 This English version of the Commission Decision is intended to be reference material to provide convenience for users.
More informationSpecies-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPAR
Species-specific kinetics and zonation of hepatic DNA synthesis induced by ligands of PPAR Abdullah Al Kholaifi *, Abeer Amer *, Brett Jeffery *, Tim J B Gray, Ruth A Roberts, David R Bell * * School of
More informationLesions Induced in Rodent Pancreas
Environmental Health Perspectives Vol. 56, pp. 245-251, 1984 Lesions Induced in Rodent Pancreas by Azaserine and Other Pancreatic Carcinogens by Daniel S. Longnecker* Focal proliferative changes in the
More informationReport of a Workshop on Dose-Response Approaches for Nuclear Receptor- Mediated Modes of Action
Report of a Workshop on Dose-Response Approaches for Nuclear Receptor- Mediated Modes of Action The 2010 Society of Risk Analysis Meeting Salt Lake City, Utah Robert Budinsky The Dow Chemical Company Outline
More informationWhat causes cancer? Physical factors (radiation, ionization) Chemical factors (carcinogens) Biological factors (virus, bacteria, parasite)
Oncogenes What causes cancer? Chemical factors (carcinogens) Physical factors (radiation, ionization) Biological factors (virus, bacteria, parasite) DNA Mutation or damage Oncogenes Tumor suppressor genes
More informationNeoplastic transformation of epithelial cells in whole mammary gland in vitro
Proc. Natl. Acad. Sci. USA Vol. 76, No. 11, pp. 5886-5890, November 1979 Medical Sciences Neoplastic transformation of epithelial cells in whole mammary gland in vitro (organ culture/7,12-dimethylbenz[alanthracene/carcinogenesis/mammary
More informationHyperplastic Nodules and Adenomas of Exocrine Pancreas in Azaserine-Treated Rats 1, 2
Hyperplastic Nodules and Adenomas of Exocrine Pancreas in Azaserine-Treated Rats 1, 2 Daniel S. Longnecker 3 and Barbara G. Crawford 3.4 SUMMARY-Long-term studies of the carcinogenicity of azaserine in
More informationStrain dependent effects of sex hormones on hepatocarcinogenesis in mice
Carcinogenesls vol.17 no.2 pp.191 196, 1996 ACCELERATED PAPER Strain dependent effects of sex hormones on hepatocarcinogenesis in mice Therese M.Poole and Norman R.Drinkwater 1 McArdle Laboratory for Cancer
More informationAspartame: the experimental evidence of cancer risks
Ramazzini Institute Cesare Maltoni Cancer Research Center Aspartame: the experimental evidence of cancer risks Dr. Morando Soffritti, MD International Scientific Conference on Early exposures and childhood
More informationI Received July 8, 1985; accepted December 23, 1985.
Effects of Phenobarbital and Secondary Bile Acids on Liver, Gallbladder, and Pancreas Carcinogenesis Initiated by N-Nitrosobis(2-hydroxypropyl)amine in Hamsters 1,2 Takao Makino,3 Takeshi Obara,3 Hitoshi
More informationMicroarray Analysis and Liver Diseases
Microarray Analysis and Liver Diseases Snorri S. Thorgeirsson M.D., Ph.D. Laboratory of Experimental Carcinogenesis Center for Cancer Research, NCI, NIH Application of Microarrays to Cancer Research Identifying
More information5. Summary of Data Reported and Evaluation
168 IARC MONOGRAPHS VOLUME 91 5. Summary of Data Reported and Evaluation 5.1 Exposure data The first oral hormonal contraceptives that were found to inhibit both ovulation and implantation were developed
More informationTherapies for DILI: NAC, Steroids or NRF-2 activators?
Therapies for DILI: NAC, Steroids or NRF-2 activators? William M. Lee, MD Professor of Internal Medicine Meredith Mosle Chair in Liver Diseases UT Southwestern Medical Center at Dallas Drug-Induced Liver
More informationGlycogen Storage Disease
Glycogen Storage Disease 1 Introduction The food we eat is usually used for growth, tissue repair and energy. The body stores what it does not use. Excess sugar, or glucose, is stored as glycogen in the
More informationConflict of Interest Statement
Specific Aspects and Approaches for Regulatory Evaluation of Pharmaceuticals in Two-Year Rodent Carcinogenicity Studies James A. Popp Stratoxon LLC Morgantown, PA Tel: 610.286.7592 popp@stratoxon.com Conflict
More informationExploring a Link Between Spy1 and Hepatocellular Carcinoma Progression
University of Windsor Scholarship at UWindsor UWill Discover Undergraduate Conference UWill Discover 2016 Mar 29th, 4:00 PM - 5:00 PM Exploring a Link Between Spy1 and Hepatocellular Carcinoma Progression
More informationNeoplasia part I. Dr. Mohsen Dashti. Clinical Medicine & Pathology nd Lecture
Neoplasia part I By Dr. Mohsen Dashti Clinical Medicine & Pathology 316 2 nd Lecture Lecture outline Review of structure & function. Basic definitions. Classification of neoplasms. Morphologic features.
More informationSummary of Feed Carcinogenicity Study. of Diphenylamine. in F344 Rats
Summary of Feed Carcinogenicity Study of Diphenylamine in F344 Rats August 2011 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted and supported
More informationCANCER. Inherited Cancer Syndromes. Affects 25% of US population. Kills 19% of US population (2nd largest killer after heart disease)
CANCER Affects 25% of US population Kills 19% of US population (2nd largest killer after heart disease) NOT one disease but 200-300 different defects Etiologic Factors In Cancer: Relative contributions
More informationORIGIN OF PULMONARY TUMORS IN RATS INDUCED BY 4-NITROQUINOLINE 1-OXIDE. (Plates I-V)
[GANN, 57, 1-7; February, 1966] UDC 616-006-021.6[616.24]:547.831.6-31:616.24-006-031.6 ORIGIN OF PULMONARY TUMORS IN RATS INDUCED BY 4-NITROQUINOLINE 1-OXIDE (Plates I-V) Kazuo MORI, Jo HIRATSUKA, Shuhei
More informationMultistep nature of cancer development. Cancer genes
Multistep nature of cancer development Phenotypic progression loss of control over cell growth/death (neoplasm) invasiveness (carcinoma) distal spread (metastatic tumor) Genetic progression multiple genetic
More informationEDITORIAL EXPERIMENTAL SKIN CANCER
EDITORIAL EXPERIMENTAL SKIN CANCER THE experimental study of skin cancer is of historical interest in that it was the first type of malignant turnout to be induced by a pure synthetic chemical compound.
More informationSummary of Inhalation Carcinogenicity Study. of Tetrachloroethylene. in BDF 1 Mice
Summary of Inhalation Carcinogenicity Study of Tetrachloroethylene in BDF 1 Mice March 1993 Japan Bioassay Laboratory Japan Industrial Safety and Health Association PREFACE The tests were contracted and
More informationIMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, psoriasis
IMO-8400, a novel TLR7, TLR8 and TLR9 antagonist, inhibits disease development in mouse models of psoriasis Weiwen e Ja Jiang, Fu-Gang Zhu, Dong Yu, Ekambar R. Kandimalla, a a, Nicola La Monica, and Sudhir
More informationScreening of novel thalidomide analogues with label-free assays and appling in the in vivo model of hepatocellular carcinoma.
Screening of novel thalidomide analogues with label-free assays and appling in the in vivo model of hepatocellular carcinoma Lajos István Nagy Ph.D thesis summary Supervisor: László Puskás, PhD, DSc Scientific
More informationRadiofrequency Radiation
Radiofrequency Radiation A Possible Human Carcinogen? Ron Melnick Retired Toxicologist NTP/NIEHS Expert Forum: Wireless Radiation and Human Health Hebrew University Medical School January 23-26, 2017 IARC
More informationTo: Recipients of JACC 42. HV/mls/JACC 42 corrigendum Brussels, 15 December 2004
EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS AISBL To: Recipients of JACC 42 HV/mls/JACC 42 corrigendum Brussels, 15 December 2004 Dear Sir or Madam, Corrigenda to JACC No. 42 - Tetrafluoroethylene
More informationAspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound
Aspartame induces lymphomas and leukaemias in rats Aspartame, a leukaemogenic compound 1 European Journal of Oncology, Vol. 10, No. 2, pp. 00-00, 2005 IN PRESS Morando Soffritti, Fiorella Belpoggi, Davide
More informationPDGF-R Expression in Preneoplastic and Neoplastic Hepatocellular Lesions: A Rat Model N-nitrosomorpholine Stop Experiment
The Korean Journal of Pathology 2006; 40: 354-60 PDGF-R Expression in Preneoplastic and Neoplastic Hepatocellular Lesions: A Rat Model N-nitrosomorpholine Stop Experiment Su Jin Kim Kyoung Tae Kim 1 Jin
More informationInduced Liver Growth, and Multistage
Enzvironimental Health Perspectives 101(Suppl 5): 163-168 (1993) Compensatory Regeneration, Mitogen- Induced Liver Growth, and Multistage Chemical Carcinogenesis by Giovanna Maria Ledda-Columbano,1 Pierpaolo
More informationExplain the laboratory diagnosis of Rabies?
Explain the laboratory diagnosis of Rabies? The standard test for rabies testing is dfa. This test has been thoroughly evaluated for more than 40 years, and is recognized as the most rapid and reliable
More informationA case study in risk assessment: aspartame
A case study in risk assessment: aspartame Herman B.W.M.Koëter Managing Director,, Brussels, Belgium Thanks to Dr Iona Pratt of the Irish Food Safety Authority for use of a number of the slides in this
More informationHepatitis B Virus Infection and Primary Hepatocellular Carcinoma
CLINICAL MICROBIOLOGY REVIEWS, July 1992, p. 275-301 Vol. 5, No. 3 0893-8512/92/030275-27$02.00/0 Copyright 1992, American Society for Microbiology Hepatitis B Virus Infection and Primary Hepatocellular
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE AND THE COMPANY Material Manufacturer Distributor Fenofibric Acid Delayed-Release Capsules, 45 mg and 135 mg. Lupin Limited Goa 403722 INDIA.
More informationSummary of Inhalation Carcinogenicity Study. of Isopropyl Acetate. in F344 Rats
Summary of Inhalation Carcinogenicity Study of Isopropyl Acetate in F344 Rats March 2009 Japan Bioassay Research Center Japan Industrial Safety and Health Association PREFACE The tests were contracted
More informationDevelopment of important genes during breast carcinogenesis
Nagoya Med. J., 107 Development of important genes during breast carcinogenesis AYA NAIKI-ITO Department of experimental pathology and tumor biology Nagoya City University Graduate School of Medical Sciences
More informationDANIEL R. DOERGE U.S. Food and Drug Administration National Center for Toxicological Research Jefferson, AR
Research support by Interagency Agreement between NTP/NIEHS and NCTR/FDA The opinions presented are not necessarily those of the U.S. FDA or NTP NCTR/FDA Research on BPA: Integrating pharmacokinetics in
More informationBiochemistry of Cancer and Tumor Markers
Biochemistry of Cancer and Tumor Markers The term cancer applies to a group of diseases in which cells grow abnormally and form a malignant tumor. It is a long term multistage genetic process. The first
More informationComplete Protection against Aflatoxin B 1 -induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry and Genotoxic Threshold
Complete Protection against Aflatoxin B 1 -induced Liver Cancer with a Triterpenoid: DNA Adduct Dosimetry and Genotoxic Threshold Bill D. Roebuck 1, John D. Groopman 2, and Thomas W. Kensler 2,3 1 Department
More informationMechanisms of Promotion and Progression of Preneoplastic Lesions in Hepatocarcinogenesis by DDT in F344 Rats
TOXICOLOGIC PATHOLOGY, vol 31, no 1, pp 87 98, 2003 Copyright C 2003 by the Society of Toxicologic Pathology DOI: 10.1080/01926230390173941 Mechanisms of Promotion and Progression of Preneoplastic Lesions
More informationICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals. Step 5
European Medicines Agency March 1998 CPMP/ICH/299/95 ICH Topic S1B Carcinogenicity: Testing for Carcinogenicity of Pharmaceuticals Step 5 NOTE FOR GUIDANCE ON CARCINOGENICITY: TESTING FOR CARCINOGENICITY
More informationCell Proliferation and Carcinogenesis
J Toxicol Pathol 2008; 21: 1 7 Review Cell Proliferation and Carcinogenesis Samuel M. Cohen 1 and Lora L. Arnold 1 1 Department of Pathology and Microbiology and the Eppley Institute for Research on Cancer,
More informationAre tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Regulatory Toxicology and Pharmacology 41 (2005) 128 133 Regulatory Toxicology and Pharmacology www.elsevier.com/locate/yrtph Are tumor incidence rates from chronic bioassays telling us what we need to
More informationToxStrategies, Inc. and Summit Toxicology
Deborah Proctor Chad Thompson, Mark Harris, Mina Suh, Laurie Haws, Chris Kirman and Sean Hays ToxStrategies, Inc. and Summit Toxicology November 2012 Research Project funded by the Cr 6 Panel of the American
More informationThe role of Hepatitis C Virus in hepatocarcinogenesis
The role of Hepatitis C Virus in hepatocarcinogenesis Laura Beretta Fred Hutchinson Cancer Research Center l8 Incidence and mortality of the five most common cancers worldwide, 2000 Incidence Lung Breast
More informationCarcinogenic effects of the low doses: the Ramazzini Institute experience. Dr. Fiorella Belpoggi. Annual Ramazzini Days 2012
Cesare Maltoni Cancer Research Centre Ramazzini Institute (CMCRC/RI) Carcinogenic effects of the low doses: the Ramazzini Institute experience Dr. Fiorella Belpoggi Annual Ramazzini Days 2012 THE CMCRC/RI
More informationUrogenital Carcinogenesis in Female CD1 Mice Induced by In utero Arsenic Exposure Is Exacerbated by Postnatal Diethylstilbestrol Treatment
Research Article Urogenital Carcinogenesis in Female CD1 Mice Induced by In utero Arsenic Exposure Is Exacerbated by Postnatal Diethylstilbestrol Treatment Michael P. Waalkes, 1 Jie Liu, 1 Jerrold M. Ward,
More informationBENZANTHRACENE, BENZOPYRENE, OR DIBENZ- ANTHRACENE
533 THE INFLUENCE OF PRELIMINARY IRRITATION BY ACETIC ACID OR CROTON OIL ON SKIN TUMOUR PRODUCTION IN MICE AFTER A SINGLE APPLICATION OF DIMETHYL- BENZANTHRACENE, BENZOPYRENE, OR DIBENZ- ANTHRACENE From
More informationweekly application of a promoting agent such as croton oil which alone is noncarcinogenic
INHIBITION OF MOUSE SKIN TUMORIGENESIS BY ACTINOMYCIN D BY HARRY V. GELBOIN, MICHAEL KLEIN, AND RICHARD R. BATES CARCINOGENESIS STUDIES BRANCH, NATIONAL CANCER INSTITUTE, BETHESDA, MARYLAND Communicated
More informationCell Organization and Responsiveness to Hormones in Vitro: Genesis of Domes in Mammary Cell Cultures
AMER. ZOOL., 15:231-236 (1975). Cell Organization and Responsiveness to Hormones in Vitro: Genesis of Domes in Mammary Cell Cultures CHARLES M. MCGRATH Division of Biology, Michigan Cancer Foundation,
More informationReview of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner
Review of the AP Part II Practical Examination Dr David Clift Co Chief Examiner General Remarks The part II practical examination involved 15 cases which were presented with sufficient clinical data to
More informationMATERIAL SAFETY DATA SHEET
MATERIAL SAFETY DATA SHEET 1. IDENTIFICATION OF THE SUBSTANCE AND THE COMPANY Material Manufacturer Distributor Fenofibrate Tablets 48 mg & 145 mg Lupin Limited Goa 403 722 INDIA Lupin Pharmaceuticals,
More information5.36 THIOPHANATE-METHYL (077)
391 5.36 THIOPHANATE-METHYL (077) TOXICOLOGY is the International Organization for Standardization (ISO) approved common name for dimethyl 4,4 -(o-phenylene)bis(3-thioallophanate) (International Union
More informationA Weight of Evidence Approach to Cancer Assessment. Alan R Boobis Imperial College London
A Weight of Evidence Approach to Cancer Assessment Alan R Boobis Imperial College London a.boobis@imperial.ac.uk Disclosure Statement Member of Board of Trustees of ILSI, Board of Directors of ILSI Europe
More informationROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS
Original Research Article Pathology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ROLE OF PROSTATIC BASAL CELL MARKER IN DIAGNOSIS OF PROSTATIC LESIONS SUBATHRA K* Department of pathology,
More informationDr/ Sherein Saeid AbdElgayed, ph.d
هللامسب Dr/ Sherein Saeid AbdElgayed, ph.d Professor of Veterinary Pathology, Cairo University, Giza, Egypt. Chairman of the Editorial Board of Arab Journal of Science & Research Publishing (AJSRP) http://www.ajsrp.com
More information(A) PCR primers (arrows) designed to distinguish wild type (P1+P2), targeted (P1+P2) and excised (P1+P3)14-
1 Supplemental Figure Legends Figure S1. Mammary tumors of ErbB2 KI mice with 14-3-3σ ablation have elevated ErbB2 transcript levels and cell proliferation (A) PCR primers (arrows) designed to distinguish
More informationEpigenetics and Toxicology
Epigenetics and Toxicology Aline.deconti@fda.hhs.gov Division of Biochemical Toxicology National Center for Toxicology Research U.S.-Food and Drug Administration The views expressed in this presentation
More informationAllinaHealthSystems 1
Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective
More information125. Identification o f Proteins Specific to Friend Strain o f Spleen Focus forming Virus (SFFV)
No. 101 Proc. Japan Acad., 54, Ser. B (1978) 651 125. Identification o f Proteins Specific to Friend Strain o f Spleen Focus forming Virus (SFFV) By Yoji IKAWA,*} Mitsuaki YOSHIDA,*) and Hiroshi YosHIKURA**>
More informationProduction of fumonisin B1 by Fusarium proliferatum in liquid culture medium, and toxicity and metabolism of fumonisin B1 in rats
Retrospective Theses and Dissertations 1993 Production of fumonisin B1 by Fusarium proliferatum in liquid culture medium, and toxicity and metabolism of fumonisin B1 in rats Semakaleng M. Lebepe-Mazur
More informationMasao Hirose 1, Yasuko Takesada, Hikaru Tanaka, Seiko Tamano, Toshio Kato and Tomoyuki Shirai
Carcinogenesis vol.19 no.1 pp.207 212, 1997 Carcinogenicity of antioxidants BHA, caffeic acid, sesamol, 4-methoxyphenol and catechol at low doses, either alone or in combination, and modulation of their
More information15-lipoxygenases and their metabolites as biomarkers for the early detection of smoking-induced non-small cell lung cancer
15-lipoxygenases and their metabolites as biomarkers for the early detection of smoking-induced non-small cell lung cancer George G Chen Department of Surgery, Cancer Centre, Faculty of Medicine, The Chinese
More information